Congestive heart failure in patients treated with doxorubicin-Reference-Cited by-同舟云学术

Congestive heart failure in patients treated with doxorubicin

Published:2003-05-19 Issue:11 Volume:97 Page:2869-2879
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Swain Sandra M.,Whaley Fredrick S.,Ewer Michael S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

2. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

3. Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.

4. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 9th ed. Boston: Little, Brown & Co, 1994: 253-256.

Cited by 1858 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragaloside IV intervenes multi-regulatory cell death forms against doxorubicin-induced cardiotoxicity by regulating AMPKα2 pathway;International Immunopharmacology;2024-12

2. Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer;Journal of Cardiology;2024-10

3. Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis;Redox Biology;2024-10

4. New insights into cardioprotection in breast cancer patients undergoing physical exercise during chemotherapy: A systematic review and meta-analysis;Current Problems in Cardiology;2024-10

5. An infusible biologically active adhesive for chemotherapy-related heart failure in elderly rats;Bioactive Materials;2024-10